Search

Displaying results 1621 - 1630 of 10000 in total
  1. Drug

    Morus rubra pollen

    go.drugbank.com/drugs/DB10373
    Approved

    Morus rubra pollen is the pollen of the Morus rubra plant. Morus rubra pollen is mainly used in allergenic testing.

    Products: Center-AL - Morus Rubra Pollen
  2. Drug

    Brivudine

    go.drugbank.com/drugs/DB03312
    ApprovedInvestigational

    Brivudine is used in the treatment of herpes zoster. Although not approved in the U.S. or Canada, it is approved in several European countries.

    Products: Mevir 125 mg Tabletten, ZOSTEX 125 MG TABLET, 7 ADET
  3. Drug

    Rufinamide

    go.drugbank.com/drugs/DB06201
    Approved

    Rufinamide is a triazole derivative and an anticonvulsant medication to treat seizure disorders like Lennox-Gastuat syndrome, a form of childhood epilepsy.

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 InducersProducts: INOVELON® 400 MG, INOVELON FILM-COATED TABLET 200 MG
  4. Drug

    DL-alpha tocopheryl acetate

    go.drugbank.com/drugs/DB14477
    Approved

    Synonyms: DL-alpha tocopheryl acetate, DL-alpha-tocopheryl acetateMixtures: Tl-hem 150, Tl-hem 150
  5. Drug

    Tolfenamic acid

    go.drugbank.com/drugs/DB09216
    Approved

    [A31824] It was discovered by scientists at Medica Pharmaceutical Company in Finland. It is used in the UK as a treatment for migraine under the name of Clotam. … Tolfenamic acid, with the formula N-(2-methyl-3-chlorphenyl)-anthranilic acid, is a nonsteroidal anti-inflammatory agent.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesProducts: TOLFEDINE TABLETS 6 MG, TOLFEDINE TABLET 60 MG
  6. Drug

    Encorafenib

    go.drugbank.com/drugs/DB11718
    ApprovedInvestigational

    BRAF V600E or V600K mutation, as detected by an FDA-approved test. … Encorafenib, also known as _BRAFTOVI_, is a kinase inhibitor. Encorafenib inhibits BRAF gene, which encodes for B-raf protein, which is a proto-oncogene involved in various genetic mutations.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 InducersProducts: BRAFTOVI® 75 MG CÁPSULAS, BRAFTOVİ 75 MG SERT KAPSÜL, 42 ADET
  7. Drug

    Pyrithione

    go.drugbank.com/drugs/DB06815
    ApprovedInvestigational

    In the crystalline state, it exists as a centrosymmetric dimer. Due to its dynamic fungistatic and bacteriostatic properties, pyrithione zinc is used to treat dandruff and seborrheic dermatitis. … Pyrithione zinc is commonly found as an active ingredient in OTC antidandruff topical treatments such as shampoos.

    Mixtures: MD CELL Scalp, D-COL Personal Hygiene Convenience kitProducts: ZINTION SÜSPANSİYON, 100 G, ZETION SUSPANSIYON (% 2, 100 G)
  8. Drug

    Holcus lanatus pollen

    go.drugbank.com/drugs/DB10395
    Approved

    Holcus lanatus pollen is the pollen of the Holcus lanatus plant. Holcus lanatus pollen is mainly used in allergenic testing.

    Products: Center-AL - Holcus Lanatus Pollen
  9. Drug

    Cycloserine

    go.drugbank.com/drugs/DB00260
    ApprovedInvestigational

    Antibiotic substance produced by Streptomyces garyphalus.

    Synonyms: cyclo-D-Serine, D-CycloserineProducts: CICLOSERINA 250 MG CAPSULAS, SIKLOCAP 250 MG KAPSUL, 500 ADET
  10. Drug

    Zanubrutinib

    go.drugbank.com/drugs/DB15035
    ApprovedInvestigational

    [A187958] Due to this enhanced selectivity towards BTK, zanubrutinib belongs to the second-generation BTK inhibitor drug group that also includes [acalabrutinib], which was approved by the FDA in 2017. … L10166] which measures the proportion of patients in a trial whose tumour is entirely or partially destroyed by a drug.

    Categories: Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexProducts: BRUKINSA 80 mg capsules